Evidence map›Paper›PMID 41022435›Full record

ArticleBMJ open2025

Stunting incidence and reversal as metrics of postnatal linear growth faltering in low- and middle-income countries: a critical appraisal and simulation study.

Daniel E Roth, Kelly M Watson, Diego G Bassani

Abstract read
In one paragraph

Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Daniel E RothDepartment of Paediatrics, University of Toronto Faculty of Medicine, Toronto, Ontario, Canada daniel.roth@sickkids.ca.ORCID http://orcid.org/0000-0001-7742-0925
Kelly M WatsonCentre for Global Child Health, The Hospital for Sick Children, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0003-4871-5112
Diego G BassaniDepartment of Paediatrics, University of Toronto Faculty of Medicine, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0001-6704-3820

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesLength-for-age z-scores (LAZ) and stunting prevalence (%LAZ <-2) are commonly used to quantify linear growth faltering in young children in low- and middle-income countries (LMICs). The Healthy Birth, Growth and Development knowledge integration (HBGDki) consortium described postnatal linear growth faltering using LAZ-by-age trajectory modelling and child-level LAZ threshold-crossing events, including incident stunting onset (first occurrence of LAZ <-2) and stunting reversal (LAZ rising from <-2 to ≥-2). Using simulations, we assessed the suitability of these LAZ threshold-crossing metrics for characterising linear growth faltering in LMICs.

methodsWe simulated a synthetic cohort with a harmonically downward-shifting LAZ trajectory from birth to 24 months of age, with mean LAZs similar to the HBGDki pooled South Asian cohorts, and without any input parameters intended to differentially affect individuals' growth across the height distribution or at different ages. We compared HBGDki empirical estimates of age interval-specific frequencies of incident stunting onset and stunting reversal with those from the synthetic cohort. Using synthetic cohorts, we examined how estimates of incident onset and reversal were affected by missing data, magnitude of the whole-population shift in the LAZ distribution and strength of the between-time-point correlation. We also compared the 3-24 month pattern of linear growth faltering expressed as age-related trajectories of average growth delay (chronological age minus height-age), mean LAZ or stunting prevalence.

resultsEmpirical estimates of age interval-specific incident stunting onset and stunting reversal in the HBGDki cohorts were similar to those observed in a synthetic cohort. Variability in LAZ threshold-crossing event rates is explained by starting LAZ, between-time-point correlation and the magnitude of the whole-population shift in the LAZ distribution. Incident stunting onset is also affected by missing data in preceding intervals. Stunting reversal occurs due to within-child variability (ie, imperfect between-time-point correlation) in the absence of any other phenomena that cause stunted children to become non-stunted at a later age. The linear growth faltering pattern based on growth delay differed from corresponding age-related trajectories of mean LAZ or stunting prevalence.

conclusionsIn longitudinal studies of linear growth faltering in LMICs, LAZ threshold-crossing indicators are byproducts of whole-population shifts in LAZ and within-child variability and should be interpreted accordingly. Reporting incident stunting onset and reversal rates, or analyses in which children are grouped by the timing of LAZ threshold-crossing events, may detract from efforts to understand when and why nearly all children in LMICs grow more slowly than expected for their age. Since mean LAZ and stunting prevalence are unsuitable for quantifying the rate and timing of population-average postnatal linear growth faltering, growth delay is recommended for consideration as a preferred metric.

Indexed as

Child DevelopmentDeveloping CountriesGrowth DisordersBody HeightChild, PreschoolComputer SimulationFemaleHumansIncidenceInfantInfant, NewbornMalePrevalenceChildEPIDEMIOLOGIC STUDIESNUTRITION & DIETETICSSTATISTICS & RESEARCH METHODS

Identifiers

PMID41022435
PMCPMC12481314

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.